Pictet - Biotech - HZ CHF
LU2319668898
Pictet - Biotech - HZ CHF/ LU2319668898 /
NAV 04.11.2024 Diff.+6,3300
Ertragstyp
Ausrichtung
Fondsgesellschaft
1.071,4500 CHF +0,59% thesaurierend
Aktien
Pictet AM (EU) ▶
Zeitraum: 6 Monate 1 Jahr Anzahl an Fonds: 10 20 50
Titel
ISIN
Performance
Volatilität
Sharpe Ratio
1.
Abaris Biotech.Opportunities A USD LU2210105313
+73,50% 40,44%
1,75
2.
Janus Henderson Horizon Biotechnology Fund IU2 EUR LU2441282626
+46,81% 20,07%
2,19
3.
J.Henderson H.BioTech.F.IU2 LU1897414568
+49,21% 21,34%
2,17
4.
J.Henderson H.BioTech.F.H2 LU1897414485
+49,02% 21,33%
2,16
5.
Janus Henderson Horizon Biotechnology Fund A2 EUR LU2441282899
+46,54% 20,40%
2,14
6.
J.Henderson H.BioTech.F.A2 LU1897414303
+48,40% 21,35%
2,13
7.
Abaris Biotech.Opportunities A CHF LU2210124454
+67,89% 40,20%
1,62
8.
HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund P Cap USD LU1540962054
+36,48% 17,58%
1,90
9.
Janus Henderson Horizon Biotechnology Fund H2 HEUR LU2441283277
+46,80% 21,43%
2,05
10.
HBM Global Biotechnology Fund A cap USD LU1540961759
+36,12% 17,60%
1,88
...
50.
Pictet - Biotech - HZ CHF LU2319668898
+30,25% 23,05%
1,19
